Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedTech SolutionsWAR:MDT +1.19%40 3-1 Month Momentum % is -36.81% as of Sep. 05, 2026. GuruFocus rates WAR:MDT with a GF Score™ of 40/100 and a GF Value™ of zł0.03 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 1,114 Retail - Cyclical companies, MedTech Solutions ranks worse than 96.77% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-05), MedTech Solutions's 3-1 Month Momentum % is -36.81%.
The industry rank for MedTech Solutions's 3-1 Month Momentum % or its related term are showing as below:
WAR:MDT's 3-1 Month Momentum % is ranked worse than 96.77% of 1114
companies
in the Retail - Cyclical industry
Industry Median: -0.575
vs WAR:MDT: -36.81
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
MedTech Solutions 3-1 Month Momentum % Related Terms
WAR:MDT vs AMZN, BABA, PDD: 3-1 Month Momentum % Comparison
For the Internet Retail subindustry, MedTech Solutions's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedTech Solutions 3-1 Month Momentum % vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, MedTech Solutions's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where MedTech Solutions's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedTech Solutions (WAR:MDT) has a 3-1 Month Momentum % of -36.81% as of Sep. 05, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on MedTech Solutions and its competitors. According to the industry distribution chart, MedTech Solutions ranks #1078 out of 1114 companies in the Retail - Cyclical industry, placing it in the top 96.8%.
Is MedTech Solutions' 3-1 Month Momentum % too high?
MedTech Solutions' current 3-1 Month Momentum % is -36.81%. Based on the distribution chart, MedTech Solutions ranks #1078 out of 1114 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, MedTech Solutions has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MedTech Solutions' 3-1 Month Momentum % compare to AMZN and BABA?
According to the Retail - Cyclical industry distribution chart, MedTech Solutions ranks #1078 out of 1114 companies for 3-1 Month Momentum %. This places MedTech Solutions in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Retail - Cyclical company?
A good 3-1 Month Momentum % depends on the Retail - Cyclical industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on MedTech Solutions and its competitors. MedTech Solutions's current 3-1 Month Momentum % is -36.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedTech Solutions stock overvalued right now?
Based on GuruFocus' analysis, MedTech Solutions (WAR:MDT) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.03, compared to a current price of zł0.34 — trading 1033.3% above its estimated fair value. The current 3-1 Month Momentum % is -36.81%. MedTech Solutions' overall GF Score™ is 40/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For MedTech Solutions (WAR:MDT), the current 3-1 Month Momentum % is -36.81% as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedTech Solutions (WAR:MDT) Overvalued in 2026?
Based on GuruFocus' analysis, MedTech Solutions stock appears to be overvalued.
The current stock price of zł0.34 is trading 1033.3% above its estimated GF Value™ of zł0.03.
GuruFocus considers MedTech Solutions to be Significantly Overvalued.
Key valuation signals for WAR:MDT:
3-1 Month Momentum %: -36.81%
GF Value™: zł0.03 vs. price of zł0.34 (1033.3% above fair value)
No single metric tells the full story. See the WAR:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedTech Solutions SA formerly E-shopping Group SA main activity is based on conducting business through its own e-shops that operate in the dropshipping sales model.
40GF Score
Get the complete analysis for WAR:MDT
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MDT has been successfully added to your 
